Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The restructuring aims to create synergies across the business and strengthen capital structure
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Subscribe To Our Newsletter & Stay Updated